drugset / Trial / NCT03613558

Dex as Analgesic Adjuvant in OSA Patients

NCT03613558

Phase 1/2 Withdrawn Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess whether intravenous peri-operative Dexmedetomidine reduces opioid requirements and or improves pain control after Uvulopalatopharyngoplasty (UPPP) in patients with obstructive sleep apnea (OSA).

Timeline

Start
2014-07
Primary completion
2015-06
Completion
2015-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous